
Clear cell renal carcinoma - evolution of metastatic disease and overall survival after four lines of targeted therapy. Case report
Author(s) -
Andreea Lăzescu,
Laura Ciurea,
Ioan Burlănescu,
D Mitulescu,
Alexandru Grigorescu
Publication year - 2017
Publication title -
oncolog-hematolog.ro
Language(s) - English
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.41.4.2017.1349
Subject(s) - temsirolimus , medicine , sorafenib , sunitinib , renal cell carcinoma , everolimus , oncology , denosumab , nephrectomy , cancer , disease , surgery , radiology , discovery and development of mtor inhibitors , kidney , pi3k/akt/mtor pathway , hepatocellular carcinoma , apoptosis , biochemistry , chemistry , osteoporosis